NCT02805504View on ClinicalTrials.gov

Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

PHASE4CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

July 11, 2016

Primary Completion Date

May 9, 2022

Study Completion Date

May 9, 2022

Conditions
Urinary Tract Diseases
Interventions
DRUG

Exparel

This group will receive intraoperative local Liposomal Bupivacaine injection at the surgical site.

DRUG

Marcaine

This group will receive intraoperative Bupivacaine HCl injection at the surgical site.

Trial Locations (1)

92350

Loma Linda Medical Center, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER

NCT02805504 - Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures | Biotech Hunter | Biotech Hunter